BillionToOne Gains Significant Momentum as Major Investors Secure Substantial New Equity Stakes
The molecular diagnostics sector is witnessing a significant shift in investor sentiment as BillionToOne emerges as a focal point for institutional capital.
by 
Josh Weiner
Josh Weiner